Comparative Genomics of Environmental and Clinical Strains Closely Related to the Highly Transmissible Epidemic ET12 Lineage

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2018 Mar 22

PMID 29559964

Citations 10

Authors

Josselin Bodilis

Elodie Denet

Elisabeth Brothier

Arnault Graindorge

Sabine Favre-Bonte

Sylvie Nazaret

Affiliations

Soon will be listed here.

Abstract

The epidemic ET12 lineage belongs to the genomovar IIIA including the reference strain J2315, a highly transmissible epidemic lineage. Members of this lineage are able to cause lung infections in immunocompromised and cystic fibrosis patients. In this study, we describe the genome of F01, an environmental strain isolated from soil in Burkina Faso that is, to our knowledge, the most closely related strain to this epidemic lineage. A comparative genomic analysis was performed on this new isolate, in association with five clinical and one environmental strains whose genomes were previously sequenced. Antibiotic resistances, virulence phenotype, and genomic contents were compared and discussed with an emphasis on virulent and antibiotic determinants. Surprisingly, no significant differences in antibiotic resistance and virulence were found between clinical and environmental strains, while the most important genomic differences were related to the number of prophages identified in their genomes. The ET12 lineage strains showed a noticeable greater number of prophages (partial or full-length), especially compared to the phylogenetically related environmental F01 strain (i.e., 5-6 and 3 prophages, respectively). Data obtained suggest possible involvements of prophages in the clinical success of opportunistic pathogens.

Citing Articles

Suppressing Tymovirus replication in plants using a variant of ubiquitin.

De Silva A, Kim K, Weiland J, Hwang J, Chung J, Pereira H PLoS Pathog. 2025; 21(1):e1012899.

PMID: 39869641 PMC: 11819560. DOI: 10.1371/journal.ppat.1012899.

HME, NFE, and HAE-1 efflux pumps in Gram-negative bacteria: a comprehensive phylogenetic and ecological approach.

Bodilis J, Simenel O, Michalet S, Brothier E, Meyer T, Favre-Bonte S ISME Commun. 2024; 4(1):ycad018.

PMID: 38371394 PMC: 10872679. DOI: 10.1093/ismeco/ycad018.

Protozoan predation enhances stress resistance and antibiotic tolerance in Burkholderia cenocepacia by triggering the SOS response.

Moron A, Tarhouchi A, Belinchon I, Valenzuela J, de Francisco P, Martin-Gonzalez A ISME J. 2024; 18(1).

PMID: 38366016 PMC: 10944698. DOI: 10.1093/ismejo/wrae014.

Comparative Genomics Identified PenR E151V Substitution Associated with Carbapenem-Resistance Complex and a Novel Complex Specific OXA-1043 Subgroup.

Liao Y, Huang Y, Tseng C, Liu C, Liu P Infect Drug Resist. 2023; 16:5627-5635.

PMID: 37662974 PMC: 10473398. DOI: 10.2147/IDR.S418969.

Metabolomic profiling of Burkholderia cenocepacia in synthetic cystic fibrosis sputum medium reveals nutrient environment-specific production of virulence factors.

Jaiyesimi O, McAvoy A, Fogg D, Garg N Sci Rep. 2021; 11(1):21419.

PMID: 34725378 PMC: 8560942. DOI: 10.1038/s41598-021-00421-4.

References

Speert D, Henry D, Vandamme P, Corey M, Mahenthiralingam E . Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis. 2002; 8(2):181-7. PMC: 3369581. DOI: 10.3201/eid0802.010163. View

Stamatakis A . RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics. 2006; 22(21):2688-90. DOI: 10.1093/bioinformatics/btl446. View

Carlier A, Agnoli K, Pessi G, Suppiger A, Jenul C, Schmid N . Genome Sequence of Burkholderia cenocepacia H111, a Cystic Fibrosis Airway Isolate. Genome Announc. 2014; 2(2). PMC: 3983312. DOI: 10.1128/genomeA.00298-14. View

Graindorge A, Menard A, Neto M, Bouvet C, Miollan R, Gaillard S . Epidemiology and molecular characterization of a clone of Burkholderia cenocepacia responsible for nosocomial pulmonary tract infections in a French intensive care unit. Diagn Microbiol Infect Dis. 2009; 66(1):29-40. DOI: 10.1016/j.diagmicrobio.2009.06.008. View

Pirone L, Bragonzi A, Farcomeni A, Paroni M, Auriche C, Conese M . Burkholderia cenocepacia strains isolated from cystic fibrosis patients are apparently more invasive and more virulent than rhizosphere strains. Environ Microbiol. 2008; 10(10):2773-84. DOI: 10.1111/j.1462-2920.2008.01697.x. View

Sievers F, Wilm A, Dineen D, Gibson T, Karplus K, Li W . Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011; 7:539. PMC: 3261699. DOI: 10.1038/msb.2011.75. View

Hearn E, Dennis J, Gray M, Foght J . Identification and characterization of the emhABC efflux system for polycyclic aromatic hydrocarbons in Pseudomonas fluorescens cLP6a. J Bacteriol. 2003; 185(21):6233-40. PMC: 219392. DOI: 10.1128/JB.185.21.6233-6240.2003. View

Foweraker J . Recent advances in the microbiology of respiratory tract infection in cystic fibrosis. Br Med Bull. 2009; 89:93-110. PMC: 7109666. DOI: 10.1093/bmb/ldn050. View

Summer E, Gill J, Upton C, Gonzalez C, Young R . Role of phages in the pathogenesis of Burkholderia, or 'Where are the toxin genes in Burkholderia phages?'. Curr Opin Microbiol. 2007; 10(4):410-7. PMC: 2064068. DOI: 10.1016/j.mib.2007.05.016. View

10.

Bocs S, Cruveiller S, Vallenet D, Nuel G, Medigue C . AMIGene: Annotation of MIcrobial Genes. Nucleic Acids Res. 2003; 31(13):3723-6. PMC: 168996. DOI: 10.1093/nar/gkg590. View

11.

Schwager S, Agnoli K, Kothe M, Feldmann F, Givskov M, Carlier A . Identification of Burkholderia cenocepacia strain H111 virulence factors using nonmammalian infection hosts. Infect Immun. 2012; 81(1):143-53. PMC: 3536147. DOI: 10.1128/IAI.00768-12. View

12.

Tomich M, Herfst C, Golden J, Mohr C . Role of flagella in host cell invasion by Burkholderia cepacia. Infect Immun. 2002; 70(4):1799-806. PMC: 127839. DOI: 10.1128/IAI.70.4.1799-1806.2002. View

13.

Youenou B, Favre-Bonte S, Bodilis J, Brothier E, Dubost A, Muller D . Comparative Genomics of Environmental and Clinical Stenotrophomonas maltophilia Strains with Different Antibiotic Resistance Profiles. Genome Biol Evol. 2015; 7(9):2484-505. PMC: 4607518. DOI: 10.1093/gbe/evv161. View

14.

Bodilis J, Youenou B, Briolay J, Brothier E, Favre-Bonte S, Nazaret S . Draft Genome Sequences of Stenotrophomonas maltophilia Strains Sm32COP, Sm41DVV, Sm46PAILV, SmF3, SmF22, SmSOFb1, and SmCVFa1, Isolated from Different Manures in France. Genome Announc. 2016; 4(4). PMC: 4991710. DOI: 10.1128/genomeA.00841-16. View

15.

Aaron S, Ferris W, Henry D, Speert D, MacDonald N . Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med. 2000; 161(4 Pt 1):1206-12. DOI: 10.1164/ajrccm.161.4.9907147. View

16.

Lynch K, Liang Y, Eberl L, Wishart D, Dennis J . Identification and characterization of ϕH111-1: A novel myovirus with broad activity against clinical isolates of . Bacteriophage. 2013; 3(4):e26649. PMC: 3829948. DOI: 10.4161/bact.26649. View

17.

Abedon S, Garcia P, Mullany P, Aminov R . Editorial: Phage Therapy: Past, Present and Future. Front Microbiol. 2017; 8:981. PMC: 5471325. DOI: 10.3389/fmicb.2017.00981. View

18.

Arndt D, Grant J, Marcu A, Sajed T, Pon A, Liang Y . PHASTER: a better, faster version of the PHAST phage search tool. Nucleic Acids Res. 2016; 44(W1):W16-21. PMC: 4987931. DOI: 10.1093/nar/gkw387. View

19.

Mullen T, Markey K, Murphy P, McClean S, Callaghan M . Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells. Eur J Clin Microbiol Infect Dis. 2007; 26(12):869-77. DOI: 10.1007/s10096-007-0385-2. View

20.

Youenou B, Hien E, Deredjian A, Brothier E, Favre-Bonte S, Nazaret S . Impact of untreated urban waste on the prevalence and antibiotic resistance profiles of human opportunistic pathogens in agricultural soils from Burkina Faso. Environ Sci Pollut Res Int. 2016; 23(24):25299-25311. DOI: 10.1007/s11356-016-7699-5. View